| scholarly article | Q13442814 |
| P2093 | author name string | Gur E | |
| Lerer B | |||
| Newman ME | |||
| Dremencov E | |||
| P433 | issue | 13 | |
| P304 | page(s) | 2925-2929 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | NeuroReport | Q15710007 |
| P1476 | title | Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain | |
| P478 | volume | 11 |
| Q28292310 | 5-HT1A receptors, gene repression, and depression: guilt by association |
| Q44374798 | Alcohol reduces prefrontal cortical excitability in humans: a combined TMS and EEG study |
| Q35000902 | DNA variation and psychopharmacology of the human serotonin receptor 1B (HTR1B) gene |
| Q37064789 | Dorsolateral prefrontal transcranial magnetic stimulation in patients with major depression locally affects alpha power of REM sleep |
| Q64078539 | Effect of adjunctive intermittent theta-burst repetitive transcranial magnetic stimulation as a prophylactic treatment in migraine patients: A double-blind sham-controlled study |
| Q42167257 | Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study |
| Q35201133 | Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. |
| Q43880279 | Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus |
| Q42599991 | Effects of repetitive transcranial magnetic stimulation on behavioral and neurochemical changes in rats during an elevated plus-maze test |
| Q48651261 | Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine |
| Q33976272 | Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations |
| Q35236721 | Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities |
| Q35608399 | Prefrontal cortex stimulation as antidepressant treatment: mode of action and clinical effectiveness of rTMS. |
| Q35107729 | Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression? |
| Q42595600 | Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation |
| Q37437784 | SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A. |
| Q51739456 | The 5-HT1B receptor - a potential target for antidepressant treatment. |
| Q44306069 | The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression |
| Q36031101 | The role of serotonin receptor subtypes in treating depression: a review of animal studies |
| Q34385977 | Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? |
| Q93143734 | Transcranial magnetic stimulation: an alternative physical treatment in depression |
| Q38025167 | Translational neuromodulation: approximating human transcranial magnetic stimulation protocols in rats |
| Q52940593 | [Vagus nerve stimulation, repetitive transcranial magnetic stimulation, and electroconvulsive therapy in the treatment of depressive disorders]. |
Search more.